Genital human papillomaviruses-prospects for vaccination

    loading  Checking for direct PDF access through Ovid

Abstract

Serological assays for the detection of antibody to the capsid proteins of the genital human papillomaviruses are now available as a result of the ability to generate in-vitro native capsid protein and virus-like particles. These reagents appear to be of value in seroepidemiological studies, but may not prove to be of diagnostic value for the detection of infection in individuals. Virus-like particles are candidate immunogens for prophylactic vaccines, and early viral proteins have potential for immunotherapies. Data from animal models have been encouraging for both approaches.

Related Topics

    loading  Loading Related Articles